CH602759A5 - - Google Patents

Info

Publication number
CH602759A5
CH602759A5 CH1465576A CH1465576A CH602759A5 CH 602759 A5 CH602759 A5 CH 602759A5 CH 1465576 A CH1465576 A CH 1465576A CH 1465576 A CH1465576 A CH 1465576A CH 602759 A5 CH602759 A5 CH 602759A5
Authority
CH
Switzerland
Application number
CH1465576A
Inventor
Marvin Gorman
Calvin Eugene Higgens
Ramakrishnan Nagarajan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH602759A5 publication Critical patent/CH602759A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • C12P35/06—Cephalosporin C; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • C12P35/08—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin disubstituted in the 7 position
CH1465576A 1969-08-12 1976-11-22 CH602759A5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84939569A 1969-08-12 1969-08-12

Publications (1)

Publication Number Publication Date
CH602759A5 true CH602759A5 (es) 1978-07-31

Family

ID=25305685

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1212570A CH594050A5 (es) 1969-08-12 1970-08-12
CH1465576A CH602759A5 (es) 1969-08-12 1976-11-22
CH1465676A CH597347A5 (es) 1969-08-12 1976-11-22

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1212570A CH594050A5 (es) 1969-08-12 1970-08-12

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1465676A CH597347A5 (es) 1969-08-12 1976-11-22

Country Status (24)

Country Link
JP (3) JPS4945594B1 (es)
AT (1) AT297932B (es)
BE (1) BE754693A (es)
BR (1) BR6915079D0 (es)
CA (1) CA954809A (es)
CH (3) CH594050A5 (es)
CS (2) CS184309B2 (es)
DE (1) DE2040141C3 (es)
DK (2) DK128017B (es)
ES (2) ES382658A1 (es)
FI (1) FI45990C (es)
FR (1) FR2068490B1 (es)
GB (1) GB1315177A (es)
IL (1) IL35065A (es)
NL (1) NL7011805A (es)
NO (1) NO132242C (es)
OA (1) OA03599A (es)
PH (1) PH12529A (es)
PL (1) PL84058B1 (es)
RO (1) RO58570A (es)
SE (2) SE384690B (es)
SU (1) SU511027A3 (es)
YU (1) YU36539B (es)
ZA (1) ZA705386B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348985A (en) 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
DE2221035C2 (de) * 1972-04-28 1982-03-25 Merck & Co., Inc., 07065 Rahway, N.J. Verfahren zur Herstellung von substituierten 6-Iminopenicillinen und 7-Iminocephalosporinen
SE421796B (sv) 1975-02-07 1982-02-01 Glaxo Lab Ltd Forfarande for rening av klavulansyra och dess salter
US6218380B1 (en) * 1975-04-17 2001-04-17 Smithkline Beecham P.L.C. Pharmaceutical compositions
US6031093C1 (en) * 1975-04-17 2001-10-16 Smithkline Beecham Plc Solid salts of clavulanic acid
US4529734A (en) * 1976-06-08 1985-07-16 Glaxo Laboratories Limited 2-Formyloxymethyl-clavam
WO2004106347A1 (en) 2003-05-28 2004-12-09 Dsm Ip Assets B.V. Cephem compound

Also Published As

Publication number Publication date
FR2068490B1 (es) 1974-02-01
PH12529A (en) 1979-05-17
AT297932B (de) 1972-04-10
NO132242C (es) 1975-10-08
JPS4945594B1 (es) 1974-12-05
DK128017B (da) 1974-02-18
FI45990B (es) 1972-07-31
GB1315177A (en) 1973-04-26
CH597347A5 (es) 1978-03-31
FI45990C (fi) 1972-11-10
CH594050A5 (es) 1977-12-30
DK128341B (da) 1974-04-16
JPS527058B1 (es) 1977-02-26
DE2040141A1 (de) 1971-03-04
JPS519370B1 (es) 1976-03-26
CS184309B2 (en) 1978-08-31
SE384690B (sv) 1976-05-17
ZA705386B (en) 1972-03-29
OA03599A (fr) 1971-03-30
IL35065A (en) 1974-05-16
YU205470A (en) 1982-02-25
ES382658A1 (es) 1972-11-01
SE415766B (sv) 1980-10-27
DE2040141C3 (de) 1973-12-06
BE754693A (fr) 1971-02-11
PL84058B1 (en) 1976-02-28
SU511027A3 (ru) 1976-04-15
NO132242B (es) 1975-06-30
RO58570A (es) 1975-09-15
BR6915079D0 (pt) 1973-03-08
CA954809A (en) 1974-09-17
DE2040141B2 (de) 1973-05-03
FR2068490A1 (es) 1971-08-27
CS184312B2 (en) 1978-08-31
IL35065A0 (en) 1970-10-30
YU36539B (en) 1984-02-29
NL7011805A (es) 1971-02-16
ES393985A1 (es) 1975-08-16

Similar Documents

Publication Publication Date Title
AU2270770A (es)
AU465452B2 (es)
AU429630B2 (es)
AU450150B2 (es)
AU2355770A (es)
AU442375B2 (es)
AU427401B2 (es)
AU470301B1 (es)
AU442380B2 (es)
AU442554B2 (es)
AU428074B2 (es)
AU428129B2 (es)
AU428131B2 (es)
AU417208B2 (es)
AU470661B1 (es)
AU438128B2 (es)
AU425297B2 (es)
AU442285B2 (es)
AU442322B2 (es)
AU442357B2 (es)
AU414607B2 (es)
AU410358B2 (es)
AU442535B2 (es)
AU442538B2 (es)
CS148817B1 (es)

Legal Events

Date Code Title Description
PL Patent ceased